Literature DB >> 31452152

Comment on: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"

Philippe Lechat1, Jacques Ropers2, Jérome Barré3, Stephane Mouly4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31452152     DOI: 10.1007/s40262-019-00814-9

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  1 in total

1.  Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?

Authors:  Didier Concordet; Peggy Gandia; Jean-Louis Montastruc; Alain Bousquet-Mélou; Peter Lees; Aude Ferran; Pierre-Louis Toutain
Journal:  Clin Pharmacokinet       Date:  2019-07       Impact factor: 6.447

  1 in total
  1 in total

1.  Authors' Reply to Lechat et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"

Authors:  Didier Concordet; Peggy Gandia; Jean-Louis Montastruc; Alain Bousquet-Mélou; Peter Lees; Aude A Ferran; Pierre-Louis Toutain
Journal:  Clin Pharmacokinet       Date:  2019-10       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.